Skip to content

Investigation of the Detection Rate of Pathogenic Viruses in the Feces of Individuals With Non-gastrointestinal Infections

Investigation of the Detection Rate of Pathogenic Viruses in the Feces of Individuals With Non-gastrointestinal Infections

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06367647
Enrollment
2000
Registered
2024-04-16
Start date
2024-05-04
Completion date
2025-12-31
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Virus Infections

Brief summary

This project is a cross-sectional study. Investigators plan to search and collect 1600 publicly published fecal metagenomic and metatranscriptome data through the Pubmed database, by summarizing and analyzing them to construct an enterovirus database. 200 apparently healthy individuals are planned to be enrolled. At the time of enrollment, fecal specimens of participants will be collected, and their demographic characteristics, disease and medication history, gastrointestinal status, dietary habits, lifestyle habits, and mental health information will be recorded. Another 200 specimens will be collected from patients with parenteral virus infection. The demographic characteristics and pathogen test results of the parenteral virus infected patients will be reviewed and recorded. By virus metagenomic sequencing on fecal specimens, investigators will identify which viruses can be detected in the intestinal tract of apparently healthy people, and to explore whether parenteral infection viruses can be detected in feces.

Interventions

None listed

Sponsors

Zhujiang Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. age ranged from 18 to 75 years; 2. no obvious symptoms and signs of the disease; 3. not taking a drug for a long time; 4. good psychological condition ; 5. no unhealthy lifestyle; 6. willing to participate in the study, sign the informed consent, fill out the questionnaire and provide fecal samples.

Exclusion criteria

1. pregnant and lactating women; 2. suffering from certain diseases, such as cardiovascular disease, digestive system disease and nervous system disease.

Design outcomes

Primary

MeasureTime frameDescription
virus infection checklist2024.3-2025.12Viral infections in the respiratory system, digestive system, urinary system, cardiovascular system, etc.

Secondary

MeasureTime frameDescription
general information of apparently healthy individuals by questionnaire2024.3-2025.12The general information of participants will be collected through questionnaire, which includes demographic characteristics, disease and medical history, gastrointestinal status, dietary habits, and lifestyle habits.
Self-Rating Anxiety Scale SAS2024.3-2025.12Apparently healthy individuals will fill out this scale. The total score of the scale is 25-100. The cut-off value of SAS standard score is 50 points, with 50-59 points indicating mild anxiety, 60-69 points indicating moderate anxiety, and 69 points or above indicating severe anxiety.
Self-rating depression scale SDS2024.3-2025.12Apparently healthy individuals will fill out this scale. The total score of the scale is 25-100, with 53 points indicating normal, 53-62 points indicating mild depression, 63-72 points indicating moderate depression, and above 72 points indicating severe depression.
Pittsburgh sleep quality index PSQI2024.3-2025.12Apparently healthy individuals will fill out this scale. The total score of the scale is 0-21 points and can be divided into three levels. PSQI score ≤ 4 indicates good sleep quality, PSQI score ≤ 7 indicates average sleep quality, and PSQI score ≥ 8 indicates poor sleep quality (sleep disorders). Higher PSQI total scores indicate poorer sleep quality.
demographic characteristics case information of parenteral virus infected patients2024.3-2025.12Investigators will retrospectively collect demographic characteristics and pathogen detection results of participants through case information.

Countries

China

Contacts

Primary ContactYumei Liu, master
liuyumei1007@163.com+8618810795365

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026